ERKNet

The European Rare Kidney Disease Reference Network

  

Journal Watch

Thrombotic microangiopathies

Post-Surgical Thrombotic Microangiopathy: Case Series and Review of the Literature.
Author(s): Sridharan M, Hook CC, Leung N, Winters JL, Go RS
Source: Eur J Haematol 2019 Jun 28;
Publication date: 2019-06-28
Monoclonal gammopathy-associated thrombotic microangiopathy.
Author(s): Yui JC, Garceau D, Jhaveri KD, Wanchoo R, Bijol V, Glezerman I, Hassoun H, Dispenzieri A, Russell SJ, Leung N
Source: Am J Hematol 2019 Jun 30;
Publication date: 2019-06-30
Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab?
Author(s): Mauras M, Bacchetta J, Duncan A, Lavocat MP, Rohmer B, Javouhey E, Collardeau-Frachon S, Sellier-Leclerc AL
Source: Pediatr Nephrol 2019 Jul;34(7):1289-1293
Publication date: 2019-07
Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.
Author(s): Menne J, Delmas Y, Fakhouri F, Licht C, Lommelé Å, Minetti EE, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA
Source: BMC Nephrol 2019 Apr 10;20(1):125
Publication date: 2019-04-10
Hemolytic uremic syndrome in a developing country: Consensus guidelines.
Author(s): Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, Patnaik SK, Sinha A, Sethi S, Hari P, Dragon-Durey MA
Source: Pediatr Nephrol 2019 Aug;34(8):1465-1482
Publication date: 2019-08
+ Show 58 more...



European Reference Networks
ERKNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit http://ec.europa.eu/health/ern